Day: January 6, 2026

SAN DIEGO, Jan. 06, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan 13, 2026 at 4:30pm PT / 7:30pm ET.   A live webcast of the presentation will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. A replay of the webcast will be available for at least 30 days following the event. About Anaptys Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases. The company’s pipeline includes rosnilimab, a pathogenic T cell...

Only one home remains in this exclusive gated community in a serene setting LAKE MARY, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to purchase a new home at Fontaine by Toll Brothers, an exclusive gated community in Lake Mary, Florida. The final quick move-in home in the community is priced at $1.175 million.Fontaine by Toll Brothers offers expansive single-family homes on seventy-foot-wide home sites. Open-concept floor plans and modern home designs feature high-end finishes and the latest in smart home technology. The final home available for sale, the Bronte Transitional quick move-in home, offers 3,400+ square feet of luxury living space with a first-floor primary bedroom suite and a delivery date in early 2026.Situated...

Electromagnetic Geoservices ASA (the “Company” or “EMGS”) releases information on vessel activity and multi-client sales during the quarter approximately 4-5 working days after the close of each quarter. The Company defines vessel utilisation as the percentage of the vessel charter period spent on proprietary or multi-client data acquisition. Downtime (technical or maritime), mobilisation, steaming, and some standby activities are not included in the utilisation rate.   The Atlantic Guardian was redelivered to her owners at the expiry of the current charter period on 20 October 2025.  The utilization for the fourth quarter was 0% compared with 31% for the fourth quarter 2024.  Multi-client revenues in the fourth quarterThe Company expects to recognize USD 3.5 million in multi-client prefunding revenue in the fourth quarter of 2025.  The...

Stjórn Skaga hefur tekið ákvörðun um að nýta kauprétt á alls 14,1% hlut í Íslenskum verðbréfum hf. („félagið“) af minnihlutaeigendum félagsins, sbr. tilkynningu Skaga þann 16. desember 2024. Kaupverðið reiknast út frá því að heildarvirði hluta sé 1,5% af eignum í stýringu félagsins þann 31. desember 2025. Gert er ráð fyrir að seljendur hlutanna fái kaupverðið greitt með 24.231.800  nýjum hlutum í Skaga sem lúta sölubanni til tveggja ára. Fjöldi hluta er reiknaður út frá meðalgengi hlutabréfa Skaga eins og það er skráð á aðalmarkaði Nasdaq Iceland síðustu 10 viðskiptadaga fyrir dagsetningu tilkynningar. Greiðsla í formi hlutabréfa er gerð með fyrirvara um samþykki hluthafa fyrir útgáfu nýs hlutafjár í Skaga til að mæta kaupverðinu, en jafnframt er heimild til uppgjörs í reiðufé. Tillaga um hlutafjáraukningu vegna kaupanna verður sett fram...

Positive results from Phase 3 HERIZON-GEA-01 results support Ziihera as the HER2-targeted agent-of-choice in HER2+ first-line metastatic GEA and Ziihera plus chemotherapy to replace trastuzumab as the new standard of care, with or without tislelizumab regardless of PD-L1 status Late-breaking results to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium (ASCO GI) on January 8, 2026 Ziihera engineered and initially developed by Zymeworks using our proprietary Azymetric™ technology platform Zymeworks is eligible to receive up to $440.0 million in milestone payments to be earned related to regulatory approvals of Ziihera in GEA in the United States, Europe, Japan, and ChinaVANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio...

GRAND RAPIDS, Mich., Jan. 06, 2026 (GLOBE NEWSWIRE) — Xtreme One Entertainment, Inc. (OTCID: XONI), parent company of Xtreme Fighting Championships (XFC), today announced that Robbie “Ruthless” Lawler, UFC Hall of Famer and former UFC Welterweight Champion, has been appointed to the Company’s Board of Directors. Lawler brings more than twenty years of elite, global experience at the highest levels of professional mixed martial arts, having competed across the UFC, Strikeforce, and EliteXC. Recognized worldwide for his longevity, competitiveness, and professionalism, Lawler adds high-impact strategic perspective, athlete credibility, and brand authority as Xtreme One continues to scale its position in live sports and combat entertainment. “Robbie represents the gold standard of toughness, professionalism, and authenticity in MMA,”...

6 January 2026 Orange: information on the total number of shares and voting rights referred to in Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers. In application of Article L. 22-10-46 of the French Commercial Code (Code de commerce), as from 3 April 2016, a double voting right is automatically granted to fully paid-up shares that have been held in registered form and under a single shareholder name for at least two years.Date Number of shares Number of treasury shares without voting rights Theoretical number of voting rights [1] Number of voting rights exercisable01/31/2025 2,660,056, 599 3,835, 000 3,172,669, 760 3,169,834, 76002/28/2025 2,660,056, 599 3,055, 955 3,172,495, 644 3,169,439, 68903/31/2025 2,660,056, 599 3,028, 955 3,173,078,...

All-new generations of ProArt, Zenbook and Vivobook laptops, plus desktops and AiO PCs deliver a complete Copilot+ PC ecosystem built for creators and everyday users KEY POINTSProArt GoPro Edition (PX13): 13″ convertible designed in partnership with GoPro has built-in GoPro Cloud access and exclusive offers for GoPro owners ProArt PZ14: Ultralight 0.79kg 14″ Snapdragon®-powered detachable tablet delivers our most powerful creator tablet performance for on-the-go professionals Zenbook A16: First Snapdragon® X2 Elite Extreme laptop redefines portability with 16″ 3K OLED display and durable sub-1.2kg all-Ceraluminum™ chassis Zenbook DUO: New, lightweight all-Ceraluminum™ design; dual 14″ 3K OLED displays; powerful performance with Intel® Core™ Ultra X9 Series 3 processor Desktops and AiOs: V...